Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#2049
ANI Pharmaceuticals, Inc. - Common Stock
81.0
8
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.21%
Monthly Change
-1.27%
6 month change
-4.27%
Year Change
-14.32%
Previous Close
82.0
7
Open
81.0
8
Low
81.0
8
High
81.0
8
Volume
62
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
ANIP
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
12.35 M
17.26 M
17.49 M
21.07 M
21.76 M
22.41 M
22.75 M
Valuation ratios
Enterprise value
536.91 M
982.97 M
939.15 M
1.27 B
1.38 B
1.78 B
1.86 B
Price to earnings ratio
-15.45
-13.55
-13.13
67.28
-53.15
23.78
21.19
Price to sales ratio
1.67
2.69
2.06
2.14
1.74
1.9
1.89
Price to cash flow ratio
22.76
174.72
20.86
8.75
16.68
9.05
8.32
Price to book ratio
1.78
1.74
2.08
2.4
2.65
3.1
0.85
Enterprise value to EBITDA ratio
18.76
131.78
11.02
7.45
10.08
6.08
5.2
Profitability ratios
Return on assets %
-0.05
-0.06
-0.06
0.02
-0.01
0.05
0.02
Return on equity %
-0.12
-0.13
-0.15
0.04
-0.05
0.14
0.05
Return on invested capital %
-13.62
-22.39
-16.37
26.94
0.23
33.79
10.85
Gross margin %
58.19
53.45
56.13
62.71
59.27
61.36
60.59
Operating margin %
-7.68
-18.41
-11.15
9.65
0.1
12.58
16.38
EBITDA margin %
13.73
3.45
26.94
35.02
22.24
33.43
33.21
Net margin %
-10.82
-19.71
-15.14
3.86
-3.01
8.87
12.42
Liquidity ratios
Quick ratio
1.39
2.74
2.4
2.81
2.02
2.19
2.52
Current ratio
2.17
3.68
3.46
3.57
2.72
2.71
3.12
Inventory turnover
—
1.41
1.48
1.68
2.02
2.39
0.65
Asset turnover
0.45
0.35
0.41
0.58
0.56
0.61
0.17
Solvency ratios
Debt to assets ratio
0.37
0.37
0.38
0.31
0.24
0.2
0.2
Debt to equity ratio
0.88
0.86
0.91
0.66
0.77
0.54
0.51
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.28
0.26
-1.92
6.54
3.31
8.73
9.96
EBIT per share
-1.34
-3.16
-2.17
2.58
0.03
5.23
5.85
EBITDA per share
2.39
0.59
5.24
9.37
7.07
13.91
16.93
Total debt per share
15.52
22.81
17.62
15.7
16.49
13.75
13.27
Cash per share
0.66
7.96
2.97
12.15
7.5
13.45
14.44
Net current asset value per share
14.24
25.55
21.17
28.57
27.32
35.48
34.68
Tangible book value per share
16.36
26.51
19.29
23.79
20.9
25.47
26.1
Working capital per share
7.67
18.6
15.06
20.57
17.29
22.38
23.56
Book value per share
16.36
26.51
19.29
23.79
20.9
25.47
26.1
News
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock
Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?
ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push
ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
ANIP Valuation: Does 9.8x Forward P/E Offer Upside?
ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge
ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy?
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised